Mineralys Therapeutics, INC. (MLYS) SEC Filings — 2024
21 SEC filings for Mineralys Therapeutics, INC. (MLYS) in 2024.
Filings
- Mineralys Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Mineralys Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Mineralys Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Mineralys Therapeutics Files 8-K — 8-K · Oct 30, 2024
- Mineralys Therapeutics Files 8-K — 8-K · Sep 25, 2024
- Mineralys Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Mineralys Therapeutics Appoints New Directors, Updates Executive Contracts — 8-K · Jun 14, 2024
- Mineralys Therapeutics Files 8-K — 8-K · Jun 10, 2024
- Mineralys Therapeutics Files 8-K — 8-K · May 31, 2024
- Mineralys Therapeutics Reports on Shareholder Votes — 8-K · May 22, 2024
- Mineralys Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Mineralys Therapeutics, Inc. Announces Annual Meeting of Stockholders — DEF 14A · Apr 9, 2024
- Mineralys Therapeutics Announces Board and Executive Changes — 8-K · Apr 4, 2024
- Mineralys Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Mineralys Therapeutics, INC. SC 13G Filing — SC 13G · Feb 15, 2024
- Mineralys Therapeutics, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Mineralys Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Mineralys Therapeutics, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Samsara BioCapital Amends Mineralys Therapeutics Stake — SC 13D/A · Feb 12, 2024
- MLYS Reports Material Agreement, Unregistered Equity Sales — 8-K · Feb 8, 2024
- Mineralys Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 4, 2024